No Placebo Group
Every participant receives an active treatment — no one gets a placebo.
Ready to participate?
Review the details below, then apply to join this clinical trial.
At a Glance
Age
20 – 70
Sex
Any
Study type
Interventional
Purpose
Health Services Research
Participants needed
200 (estimated)
Sponsor
NYU Langone Health · Other
Who this trial is looking for
This trial is looking for people who were diagnosed with diabetes in the emergency department. Participants will help identify reasons why some may not follow up with their doctor after the diagnosis and test a new way to connect them to care.
Are You a Good Fit for This Trial?
You may be able to join if
I have received lab tests in the emergency department
I have an HbA1c test result of 6.5% or higher
I live in New York City or Long Island
My primary language is English or Spanish
I can provide informed consent
You may not be able to join if
I have no prior history of diabetes
I have a medical condition that could affect my HbA1c test results
Summarized in plain language from this trial's official eligibility criteria.
The full criteria are further down this page — only the research team can
confirm whether you qualify.
Think this trial could be right for you?
Answer three quick questions written from this study's own rules to see if you may qualify. No account needed to find out.
This goal of this NIH funded R01 study is to identify risk factors for not being able to follow-up for a new diagnosis of diabetes in the emergency department and improve linkage of these newly diagnosed patients to appropriate outpatient care. Its three aims will be accomplished through 1) a retrospective chart review of emergency department (ED) patients screened for diabetes, 2) a series of pro…
This goal of this NIH funded R01 study is to identify risk factors for not being able to follow-up for a new diagnosis of diabetes in the emergency department and improve linkage of these newly diagnosed patients to appropriate outpatient care. Its three aims will be accomplished through 1) a retrospective chart review of emergency department (ED) patients screened for diabetes, 2) a series of prospective qualitative interviews among ED patients with newly diagnosed diabetes who fail to follow-up for outpatient care, and 3) a simple randomized controlled trial to test the efficacy of telehealth bridge visits to connect ED patients with newly diagnosed diabetes to outpatient primary care.
Trial Locations
Loading…
Loading trial locations…
Facility
City
State
Country
Status
Eligibility Criteria
Inclusion Criteria:
* Emergency patient receiving lab tests with an initial HbA1c test result of ≥ 6.5%
* Residential address in New York City or Long Island
* Primary language is English or Spanish
* Able to provide informed consent
Exclusion Criteria:
* No prior history of diabetes
* No medical…
Inclusion Criteria:
* Emergency patient receiving lab tests with an initial HbA1c test result of ≥ 6.5%
* Residential address in New York City or Long Island
* Primary language is English or Spanish
* Able to provide informed consent
Exclusion Criteria:
* No prior history of diabetes
* No medical condition that would result in a spurious HbA1c test (e.g., sickle cell, recent blood loss)
Picking one helps us show the most relevant trials first.
Your results are loading in the background — you can
change this any time from the results page.
Set your location to continue
Find My Trials uses your location to surface clinical trials near you.
Add your city or zip code to your profile and try again.